Dr. Reddys Labs (RDY) Misses Q2 EPS by 3c

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.06, $0.03 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $853 million versus the consensus estimate of $858.61 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Capri stock surges on potential buyer interest report
• Garg Group claims 46% shareholder backing in Better board fight
• BHG Financial Earns Great Place to Work(R) Certification, Celebrating a Culture Built Around Its People